A fund backed by Chinese billionaire Jack Ma and Singapore’s state-owned investment firm Temasek Holdings Pte made new investments in contract genomics organization WuXi NextCODE, which is expanding in China as the country pushes into the emerging field of precision medicine.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com